Target intelligence / Profile preview

Myocardial energy metabolism pathways

Molecular classification
Other
01

Overview

Myocardial energy metabolism pathways comprise the network of biochemical processes responsible for generating ATP in the heart. The adult myocardium primarily uses fatty acid oxidation for energy (60–90% of ATP), with glucose, lactate, ketone bodies, and amino acids as additional substrates[1][2][3][4][5]. The regulation and flexibility of these pathways are essential for cardiac function and adaptation to changing physiological or pathological conditions. Dysregulation or impairment of cardiac metabolism is a central feature in various forms of heart disease, such as heart failure and ischemia[1][2][4][5]. Therapeutic strategies targeting myocardial metabolism, including agents directing substrate preference, mitochondrial function, or energy efficiency, are under investigation for treating cardiovascular diseases[2][5]. The processes involved are not a discrete target, but rather coordinated systems regulated by multiple enzymes (e.g., CPT1 for fatty acid entry, PDK4 for glucose oxidation), transcription factors (e.g., PPARs, PGC-1α), and signaling pathways[1][2][4]. In summary, "myocardial energy metabolism pathways" is not a molecular target but rather a functional and regulatory framework encompassing numerous enzymatic steps and transporters in cardiac energy metabolism.

Other names
cardiac energy metabolismmyocardial metabolic pathwayscardiac metabolism
02

Mechanism of action

Modulation of substrate utilization (e.g., shifting from fatty acid to glucose oxidation), mitochondrial function enhancement, reduction of oxidative stress.

03

Biological functions

ATP generationSupport of myocardial contractilityMetabolic flexibilitySubstrate utilization regulation
04

Disease associations

Cardiovascular diseaseHeart failureMyocardial ischemia
05

Safety considerations

Off-target metabolic effectsHypoglycemia or impaired fatty acid oxidationRisk of arrhythmia with excessive metabolic shifts
06

Interacting drugs

trimetazidine

4 more in the full profile.

07

Biomarkers

Metabolites (e.g., lactate, ketone bodies, fatty acids)Imaging-based metabolic flux measurementsExpression levels of key enzymes (e.g., CPT1, PDK4, PGC-1α)

Beyond the preview

Go deeper on Myocardial energy metabolism pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myocardial energy metabolism pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call